Showing results (1-10 of 252) with videos related to
Sort By:
Pageof 26
Trends in Molecular Medicine|May 4, 2004
Vesicular stomatitis virus: re-inventing the bulletBrian D Lichty, Anthony T Power, David F Stojdl, et al.Nature Reviews. Cancer|July 4, 2014
Going viral with cancer immunotherapyBrian D Lichty, Caroline J Breitbach, David F Stojdl, et al.Human Gene Therapy|September 9, 2004
Vesicular stomatitis virus: a potential therapeutic virus for the treatment of hematologic malignancyBrian D Lichty, David F Stojdl, Rebecca A Taylor, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunityAnthony T Power, Jiahu Wang, Theresa J Falls, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 1, 2007
Cell-based delivery of oncolytic viruses: a new strategic alliance for a biological strike against cancerAnthony T Power, John C BellCurrent Opinion in Molecular Therapeutics|January 27, 2009
Diplomatic immunity: turning a foe into an allyKelley A Parato, Brian D Lichty, John C BellEbiomedicine|July 14, 2016
Oncolytic Viruses: Therapeutics With an Identity CrisisCaroline J Breitbach, Brian D Lichty, John C BellCancer Cell|October 31, 2003
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agentsDavid F Stojdl, Brian D Lichty, Benjamin R tenOever, et al.The Journal of General Virology|October 13, 2006
Matrix protein of Vesicular stomatitis virus harbours a cryptic mitochondrial-targeting motifBrian D Lichty, Heidi McBride, Stephen Hanson, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 24, 2009
Intelligent design: combination therapy with oncolytic virusesKathryn Ottolino-Perry, Jean-Simon Diallo, Brian D Lichty, et al.Pageof 26